We showed that in a Canadian population of adults at risk for T2D, those with higher serum proportions of marine-derived n-3 PUFAs within the total lipid pool at baseline had significantly lower levels of sCD163 in the following years. This evidence concerns the gene CD163 and type 2 diabetes mellitus.